I know the submission was accepted, that's why RSH announced they submitted this to the FDA. Just thought it was strange given there were "significant" change to the new generation algorithm, the FDA doesn't take into this clinical data especially if the previous version of Wheezo got tested against the spirometry, do you know if that's the case?
